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Introduction
Soft-tissue tumours include a wide spectrum of pathologies, ranging from benign to high grade malignancies. Soft-tissue tumours can occur anywhere, but most often arise in the extremities. 1 When sarcomas at all sites are considered there is a high incidence of local recurrence (25%) and a five-year survival between 50% and 60% 2 . Local recurrence and disease-specific survival are closely related to tumour grade, size, depth, site and incomplete surgical resection margins. [3] [4] [5] [6] Abdominal wall sarcomas account for between 1 -5% of all soft-tissue sarcomas 7 . Similar surgical principles apply to sarcomas in the abdominal wall namely complete surgical excision with negative histological margins.
Fibromatosis or abdominal wall desmoids are benign, slow-growing tumours of myofibroblast origin with a propensity for local aggressive behaviour but with a lack of metastatic potential. In the extremities, fibromatosis has a reputation for local recurrence that can occur regardless of margin status 8 schwannomas, haemangiomas can also rarely occur in the abdominal wall and cause local symptoms and concern. The purpose of this study is to report on the pathological spectrum of tumours resected at a single institute and to discuss the outcome after surgical resection and abdominal wall reconstruction in this diverse group of tumours.
Patients and Methods
Patients with soft-tissue tumours resected from the abdominal wall from January 2000 until January 2009 were identified from a prospectively-kept database. The pathological and clinical records of these patients were reviewed.
The abdominal wall was defined as the region between the costal margins and the inguinal ligaments with the lateral aspect of the paravertebral muscles defining the lateral borders. Macroscopic margins were ascertained by the operating surgeon confirming either complete surgical excision or residual tumour. Microscopic margins were assessed at histopathology examination.
Patients that were deemed inoperable or who declined surgery were not 
Results

Pathology and diagnosis
During the period January 2000 to Jan 2009, 92 patients underwent resection of tumours involving the abdominal wall. The patient demographics and pathological spectrum for the whole cohort is shown in Table 1 . Pain was an infrequent presenting feature for all pathologies other than endometriosis, with most patients presenting with an asymptomatic abdominal mass. 
Surgical outcome and complications
In total, 92 patients underwent 93 resections of abdominal wall tumours; one patient underwent a re-resection of a recurrent sarcoma within the study period. In 87 of the 93 operations (94%), a mesh reconstruction of the abdominal wall was required and 5 patients with small benign tumours did not require mesh reconstruction. The median length of stay for the whole cohort was 5 days with a range of 1 -32 days.
In all but 2 of these cases there was no requirement for associated skin reconstruction and primary closure of the skin could be obtained directly over the mesh. In two cases primary skin closure could not be achieved and a Analysis using Kaplan-Meier survival plots for local recurrence indicated that recurrence was significantly associated with tumour size (higher recurrence rates for tumours >10cm, P= 0.0024), grade (higher recurrence rate in high grade tumours, P = 0.0021). Microscopically clear margins were associated with improved disease-free survival (P=0.03) and approached, but did not attain, significance for local recurrence (P=0.08). Seven patients ( Radiotherapy can be used in abdominal wall sarcomas but its use is limited by the radiosensitivity of surrounding structures especially small bowel, liver and kidneys. Further studies are necessary to examine treatment planning with conformal therapies such as intensity-modulated radiation therapy in an attempt to avoid toxicities and decrease the high incidence of local and a large abdominal wall sarcoma (Figure 3b ). Both diagnoses were made preoperatively by clinically guided percutaneous core biopsy -end of text -
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